Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups

Background: 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been used to prevent pneumococcal disease, and PPSV23 became available in 2003 in Hangzhou, China as a private-sector, vaccinee-chosen vaccine. No national guidelines for PPSV23 have been developed. We analyzed PPSV23 coverage an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Hum Vaccin Immunother
Hoofdauteurs: Liu, Yan, Xu, Yuyang, Wang, Jun, Che, Xinren, Gu, Wenwen, Du, Jian, Zhang, Xiaoping, Zhang, Xuechao, Jiang, Wei, Chen, Junfang, An, Zhijie
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2020
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7872049/
https://ncbi.nlm.nih.gov/pubmed/32530728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1765620
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items